Keywords: GlaxoSmithKline, Cellzome, M&A, Proteomics technologies

GlaxoSmithKline buys full control of Cellzome

Article | 16 May 2012

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) has signed an agreement to fully acquire privately held Cambridge based Cellzome for £61 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in